SERAFINI-LAMANNA TONY (Executive VP-Diagnostics) reported 1 transaction at MERIDIAN BIOSCIENCE INC
Review the transaction codes below to understand the nature of each event.
Filed: 10/5/2022ACC: 0001127602-22-023692
Officer· Executive VP-Diagnostics
Since May 2020
-357.00
Net shares
Net seller
$11.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
357.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−357.00
Price / share
$32.14
Trade value
$11.47K
% of position
0.9%
9/16/2022
40.20K→39.85K
Total
Net shares
−357.00
Net value
-$11.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2022 | F · Tax Withholding | −357.00 | $32.14 | $11.47K | 0.9% | 40.20K | 39.85K |
| Total | −357.00 | -$11.47K | ||||||
Derivative Transactions0
No derivative transactions reported